CNTX Context Therapeutics
- 1.6800
- -0.1900-10.16%
- 1.6903
- +0.0103+0.61%
Context Therapeutics News
Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avidity Partners Management LP(9.9%),Avidity Partners Management (GP) LLC(9.9%), etc.
Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.89%),Deep Track Biotechnology Master Fund, Ltd.(9.89%), etc.
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Minai-Azary Jennifer Lynn
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levit Alex C.
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lehr Martin A.
Context Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Affinity Healthcare Fund, LP (EIN(2.06%),Affinity Asset Advisors, LLC (EIN(2.06%)
Context Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Martin Lehr(8.8%),Martin Lehr 2000 Trust(5.1%), etc.
Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Opaleye Management Inc.(5.14%)
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kantoff Philip W.
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director West Linda
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stacey Jennifer Evans
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERMAN RICHARD J
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities
Context Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Martin Lehr(7.3%),Martin Lehr 2000 Trust(5.1%), etc.
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities
Context Therapeutics | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
